University of California, San Francisco - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

University of California, San Francisco - Pharmaceuticals & Healthcare - Deals and Alliances Profile

University of California, San Francisco - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
University of California, San Francisco - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
63 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

University of California, San Francisco (UCSF), a subsidiary of University of California, is an education and research institution. The university provides resourcing and training programs; education, research and patient care services. It provides professional educational courses in dentistry, medicine, nursing and pharmacy. UCSF serves in the areas of cancer, children's health, diabetes, heart and vascular; immunology and infectious diseases; stem cells, transplant services, neurology and neurosurgery; translational medicine and women's health. The university conducts research in the areas of basic science investigation, translational research and precision medicine.

University of California, San Francisco - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals whi

  
Source:
Document ID
GDPH42358D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables41
  List of Figures51
University of California, San Francisco, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201652
University of California, San Francisco, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201671
University of California, San Francisco, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201681
University of California, San Francisco, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201692
University of California, San Francisco, Medical Devices Deals, 2010 to YTD 2016111
University of California, San Francisco, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016123
University of California, San Francisco, Pharmaceuticals &Healthcare, Deal Details1542
  Partnerships151
    Xcell Biosciences Enters into Partnership with University of California, San Francisco151
    Selvita Enters into Agreement with University of California, San Francisco161
    Natera Enters into Research Agreement with University of California, San Francisco171
    UCSF Partners with Berkeley Lights181
    BioCision Partners with University of California191
    UC San Francisco Enters into Research Agreement with GlaxoSmithKline201
    Celgene Partners with Recombinant Antibody Network212
    BioMotiv, University of California San Francisco and University of Washington Center for Commercialization Form Joint Venture231
    Sutro Biopharma Enters into Agreement with University of California, San Francisco241
    Daiichi Sankyo Enters Into Co-Development Agreement With Ucsf252
    NeoStem Enters Into Agreement With University of California, San Francisco To Develop Human Regulatory T Cells272
    Onyx Pharma And UCSF Helen Diller Family Comprehensive Cancer Center Enter Into Co-Development Agreement291
    Centers For Therapeutic Innovation Partners with UC San Francisco301
    uniQure Enters Into Agreement With University of California, San Francisco To Develop Gene Therapy For Parkinson Disease312
    DNAnexus Enters Into Co-Development Agreement With Geisinger Health System And University of California332
    University of California Enters Into Research Agreement With Sanofi352
    Sanofi-Aventis Enters Into Research Agreement With UCSF372
    UCSF Enters Into Co-Development Agreement With Sanofi-Aventis391
    Bayer HealthCare Enters Into Research Agreement With University of California401
    Bayer Schering Pharma Enters Into Research Agreement With University of California, San Francisco411
    UCSF Enters Into Co-Development Agreement With Anacor Pharma And LFKRI Of New York Blood Center422
    University of California, San Francisco Enters Into An Agreement With Pfizer442
    UCSF Enters Into Drug Discovery Agreement With Genentech461
  Licensing Agreements471
    Pliant Therapeutics Enters into Licensing Agreement with UC San Francisco471
    Optikira Enters into Licensing Agreement with University of California, San Francisco and University of Washington481
    SeraCare Life Sciences Enters into Licensing Agreement with University of California491
    Calico Life Sciences Enters into Licensing Agreement with University of California, San Francisco501
    NeoStem Enters Into Licensing Agreement With University of California, San Francisco512
    Carl Zeiss MicroImaging Enters Into Licensing Agreement With University of California, San Francisco531
    UCSF Enters Into Licensing Agreement With Zcube541
    Stromedix Enters Into Licensing Agreement With University of California, San Francisco551
    Celera Enters Into Licensing Agreement With University Of California561
University of California, San Francisco - Key Competitors571
Key Employees582
Locations And Subsidiaries603
  Head Office601
  Other Locations &Subsidiaries603
Appendix631
  Methodology631
  About GlobalData631
  Contact Us631
  Disclaimer631

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "University of California, San Francisco - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/University-of-California-San-Francisco-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-13654>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). University of California, San Francisco - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/University-of-California-San-Francisco-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-13654>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research